DNTH position history
The shares of Dianthus Therapeutics (DNTH) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q3: 1,217,554 shares, $17M, 0.67% of portfolio, New
- 2023 Q4: 1,217,554 shares, $13M, 0.46% of portfolio
- 2024 Q1: 2,717,554 shares, $82M, 2.6% of portfolio, Add +123.2%
- 2024 Q2: 2,917,231 shares, $75M, 3.2% of portfolio, Add +7.3%
- 2024 Q3: 2,917,231 shares, $80M, 4.1% of portfolio
- 2024 Q4: 2,873,000 shares, $63M, 6.2% of portfolio, Reduce −1.5%
- 2025 Q1: 1,720,902 shares, $31M, 5.9% of portfolio, Reduce −40.1%
- 2025 Q2: 1,742,902 shares, $32M, 6.5% of portfolio, Add +1.3%
- 2025 Q3: 3,204,184 shares, $126M, 28.7% of portfolio, Add +83.8%
- 2025 Q4: 2,104,184 shares, $87M, 25.0% of portfolio, Reduce −34.3%
- 2026 Q1: 4,208,368 shares, $361M, 41.8% of portfolio, Add +100.0%
- 2026 Q2: 2,104,184 shares, $205M, 32.8% of portfolio, Reduce −50.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|